https://www.cnbc.com/2023/08/08/novavax-nvax-q2-2023-earnings-report.html
-
Shares of Novavax jumped as much as 20% after the Covid vaccine maker reported a surprise second-quarter profit.
-
The results come as Novavax works to strengthen its financial position, especially after it raised doubts about its ability to stay in business earlier this year.
-
The company is pinning its hopes on the launch of its updated Covid-19 shot this fall, a global cost-cutting push launched in May and a promising vaccine pipeline to help it stay afloat.Â